China Lighting Source Industry Report, 2011-2012

In recent years, the traditional lighting is increasingly replaced. With the application and promotion of high-efficient environment-friendly lighting, the semiconductor lighting industry has developed steadily as a highlight inside the industry. According to the data of China Illuminating Engineering Society, China’s semiconductor lighting output value reached RMB13.9 billion in 2010 and RMB18.8 billion in 2011; in 2013, the output value is expected to hit RMB48.9 billion.

Landscape lighting is the main market in the field of the semiconductor lighting. In 2011, Chinese LED landscape lighting market valued RMB14.9 billion, making up 79.3% of the total semiconductor lighting market value. Meanwhile, with the widening scope of applications, the LED landscape lighting market size will present a steady growth momentum.

Request a Sample for or Inquire before buying the report@

China Lighting Source Industry

In addition, indoor lighting is a fastest growing market in the field of the semiconductor lighting. In 2011, Chinese indoor semiconductor lighting market valued RMB637 million, soaring 295.7% from the previous year. As its prices further fall, LED lighting will by degrees tap into the fields of commercial lighting and civil lighting gradually, and substitute for traditional lighting.

The report covers:

1.       Market size and demand of China lighting industry;

2.       Import and export of products;

3.       Market size and demand of the industry segments;

4.       Market size, demand and competition pattern of China LED lighting industry, industry segments and related sectors;

5.       Output and market share by region;

6.       Profile, operation, finance, dynamics, strategy and planning of key players.

Major points covered in Table of Contents of this report include:

Overview of Electric Light Source Manufacturing in China

Market Analysis of Electric Light Source Manufacturing in China

Competition Analysis of Electric Light Source Manufacturing in China

Regional Operation of Electric Light Source Manufacturing in China

Key Enterprises

See More Energy and Power Market Research Reports

Report Details :
Published:   March 2012

No. of Pages:  

Price:    Single User License - US $ 1500

Corporate User License- US $ 2200

New Product Development Trends in Store Brands

Private label penetration is in the US is much lower than it is in many of Europe’s developed markets.But a wave of new private label introductions focused on key issues like health, wellness, affordability and quality has the potential to narrow this gap.Innovative new premium offerings in health & beauty care, as well as food and beverage promise to take private label to a new level. See how private label marketers are addressing key consumer needs and are gaining share in the process.

Your key questions answered

Is the consumer shift to private label products to save money continuing, or has it stalled?

What value metrics really matter to consumers today?

What product categories are the most popular for new private label offerings? Which categories are the least prolific?

How are private labels addressing consumer health & wellness concerns?

How is private label faring in regard to the trend toward products that address “green” concerns?

Request a Sample for or Inquire before buying the report@

 Development Trends in Store Brands Market

Features and benefits

The market for private label consumer packaged goods is entering a critical new era in the US. An improving economy is challenging store brands.

See how consumer attitudes toward value and private label offerings are changing. Look at how private label is capitalizing on changing markets.

Witness how private label is adapting to trends like health, wellness, indulgence, and sustainability. View outstanding private label innovations.

Major points covered in Table of Contents of this report include:

INTRODUCTION

EXECUTIVE SUMMARY

See More Consumer Goods Market Research Reports

Report Details :
Published:   March 2012

No. of Pages:  

Price: Single User License – US $ 1495

China TV Shopping Industry Report, 2011

As one of the largest TV shopping platforms in China, HappiGo was incorporated by Radio, Film & TV Bureau of Hunan Province in 2006; since the inception, it has sold over 12 million pieces of commodities, with gross sales surmounting RMB9.4 billion, and television signals covering 16 provinces and three municipalities (Chongqing, Tianjin and Beijing) nationwide. As of end-2011, its television coverage has spread to over 60 million households. According to HappiGo’s new strategy, it will take gradual step in converting from a TV shopping media into an all media retail enterprise, and is expected to obtain online shopping revenue leveling out that from the existing TV shopping business by 2013.

Oriental CJ is China’s first home shopping channel, a joint venture by Shanghai Media & Entertainment Group and South Korea’s CJ Group. With 14 regions in service, it has nearly 18.39 million audience nationwide. In March 2011, Oriental CJ received a standard national operating license from SARFT. For the next few years, it will continue to keep a strong foothold in the Yangtze River Delta region, and extend its influence to other regions of the country step by step.

Request a Sample for or Inquire before buying the report@

China TV Shopping Industry

China TV Shopping Industry Report, 2011 by ResearchInChina mainly covers the following content:

Development of foreign and domestic TV shopping industry, covering industrial chain, industry status, market size, operation mode, competitive features & pattern, development trends, etc.;

Research on key TV shopping operators in China, involving operation and development status of nine enterprises like HappiGo, Oriental CJ and Acorn International.

Major points covered in Table of Contents of this report include:

Definition and Mode of TV Shopping

TV Shopping Industry Chain

Development Environment of TV Shopping Industry

Current Status and Competition of TV Shopping Industry

Foreign and Domestic TV Shopping Companies

Risks & Prospects of TV Shopping Industry

See More Semiconductor and Electronics Market Research Reports

Report Details :
Published:   March 2012

No. of Pages:  

Price:    Single User License - US $ 1500

Corporate User License- US $ 2200

Brazil - Car Theft and Insurance | ReportsnReports

SBD’s report Brazil – Car Theft & Insurance gives a comprehensive guide to the market situation in Brazil and summarises the status of vehicle theft in the country. The reasons for theft, methods and theft reduction initiatives are discussed and the main requirements outlined by the CONTRAN Regulation 245 are analysed.

This report also takes a detailed look at how the insurance system works and the different types of insurance policies that are available. The requirements used by the insurance industry to assess damage and repairability and vehicle security are also examined.

Request a Sample for or Inquire before buying the report@

Car Theft & Insurance Industry

This report will help you:

·         Analyse the main reasons behind car theft in Brazil and the measures taken to reduce it;

·         Discover which cars are most at risk of being stolen and what happens to the cars that are stolen;

·         Understand how car insurance premiums are calculated including vehicle specific and driver specific factors;

·         Learn how damage and repairability assessments are conducted and how car security ratings are calculated.

Brazil is a fast emerging market in the developing world. As a part of the BRIC group of countries, Brazil’s economy has seen sustained growth; overtaking the UK at the end of 2011 to become the 6th largest economy in the world.
Unfortunately, Brazil suffers from a high rate of car theft. Although theft rates suggest that the situation is improving, the truth is that the increased wealth in the country and subsequent increase in car parc has resulted in statistics that do not portray the real situation.

The legislation has been delayed several times and mandatory fitment of tracking devices is now as follows:

• 20% of total production for the domestic market – By 30 August 2012;
• 40% of production total for the domestic market – By 30 October 2012;
• 70% of production total for the domestic market – By 30 January 2013;
• 100% of production total for the domestic market – By 30 March 2013;

Major points covered in Table of Contents of this report include:

Executive summary

Market Analysis

Theft Overview

Insurance Situation

Vehicle Security Requirements

See More Banking and Financial Services Market Research Reports

Report Details :
Published:   January 2012

No. of Pages:  

Price:    Single User License - US $ 2650

Treatment Algorithms: Alzheimer's Disease – Off-label prescribing driven by dearth of treatment options

The use of combination therapy increases at second line and in more severe patients. In the US, combination therapy is apparent even at first-line treatment of moderate and severe Alzheimer’s disease, indicating that neurologists are willing to initiate therapy of an advanced patient with a cholinesterase inhibitor and memantine.

Your key questions answered

·         How does each drug’s patient share vary by disease severity and line of therapy?

·         What can be done to influence the patient pathway to increase market share?

·         What is the realistic patient population that a new market entrant can target?

·         How has generic donepezil affected prescribing behaviors in the US?

Request a Sample for or Inquire before buying the report@

Alzheimer's Disease

Features and benefits

·         Quantify the prevalent, diagnosed, and treated Alzheimer’s disease patient populations in each of the seven major markets.

·         Analyze physician prescribing habits by disease severity and line of therapy.

·         Understand how treatment and compliance rates vary according to disease severity.

·         Identify opportunities for increasing market share through effective product positioning.

Major points covered in Table of Contents of this report include:

Executive summary

COUNTRY TREATMENT TREES

DISEASE DEFINITION AND DIAGNOSIS

PATIENT SEGMENTATION

CURRENT TREATMENT OPTIONS

BIBLIOGRAPHY

See More Healthcare Market Research Reports

Report Details :
Published:   March 2012

No. of Pages:  

Price:    Single User License - US $ 7600

                Corporate user License- US $ 19000

Packaged Food in Bulgaria

The quality of Bulgarian packaged food products was the subject of some debate over the review period and particularly in 2010. Due to consumer complaints about the quality of many products, the government proposed and introduced several quality standards for the production of meat and products made from meat, cheese, yoghurt and vegetable spread, known in Bulgaria as lyutenitsa. The standards met with only moderate success but they are expected to be enforced much more strictly over the forecast period.

Global financial crisis weakens but does not seriously damage the Bulgarian market:

Bulgaria saw unprecedented economic growth over the review period. However, the global economic crisis and the deepening recession have also affected the country. The country entered recession in 2008, a few months after Western European countries, and the effects of the financial crisis became more evident over the 2009-2011 period as disposable incomes fell, unemployment rose and sales declined to some extent in all areas of the economy. As a whole, however, Bulgaria was not as seriously affected by the recession as most other EU countries.

Request a Sample for or Inquire before buying the report@

Bulgaria Packaged Food Market

Our market research reports answer questions such as:

What is the market size of Packaged Food in Bulgaria?

What are the major brands in Bulgaria?

As economic prospects slowly improve, are consumers starting to eat out more and spending less time cooking at home?

How is private label performing in the wake of retail consolidation and the global economic hangover?

Do consumers want value for money or added value?

Why buy this report?

Gain competitive intelligence about market leaders

Track key industry trends, opportunities and threats

Inform your marketing, brand, strategy and market development, sales and supply functions

This industry report originates from Passport, our Packaged Food market research database.

Major points covered in Table of Contents of this report include:

Executive summary
FOODSERVICE – KEY TRENDS AND DEVELOPMENTS
IMPULSE AND INDULGENCE PRODUCTS – KEY TRENDS AND DEVELOPMENTS
NUTRITION/STAPLES – KEY TRENDS AND DEVELOPMENTS
MEAL SOLUTIONS – KEY TRENDS AND DEVELOPMENTS
Packaged Food in Bulgaria - Company Profiles
Magre - Frozen Foods EOOD in Packaged Food (Bulgaria)

See More Food and Beverages Market Research Reports

Report Details :
Published:   March 2012

No. of Pages:  

Price:    Single User License - US $ 6500

Pharmacogenomic Partnering Terms and Agreements

The report provides a detailed understanding and analysis of how and why companies enter pharmacogenomic partnering deals. The majority of deals are discovery or development stage whereby the licensee obtains a right or an option right to license the licensors pharmacogenomic technology. These deals tend to be multicomponent, starting with collaborative R&D, and commercialization of outcomes.

Understanding the flexibility of a prospective partner’s negotiated deals terms provides critical insight into the negotiation process in terms of what you can expect to achieve during the negotiation of terms. Whilst many smaller companies will be seeking details of the payments clauses, the devil is in the detail in terms of how payments are triggered – contract documents provide this insight where press releases do not.

This report contains over 500 links to online copies of actual pharmacogenomic deals and contract documents as submitted to the Securities Exchange Commission by companies and their partners. Contract documents provide the answers to numerous questions about a prospective partner’s flexibility on a wide range of important issues, many of which will have a significant impact on each party’s ability to derive value from the deal.

The initial chapters of this report provide an orientation of pharmacogenomic dealmaking and business activities. Chapter 1 provides an introduction to the report, whilst chapter 2 provides an overview of the trends in pharmacogenomic dealmaking since 2005, including details of average headline, upfront, milestone and royalty terms.

Pharmacogenomic Partnering Terms and Agreements Market

Published: February 2012
No. of Pages:538
Price: Single User License: US$ 2695                   Corporate User License: US$ 13475 

Pharmacogenomic Partnering Terms and Agreements includes:

• Trends in pharmacogenomic dealmaking in the biopharma industry since 2007
• Analysis of pharmacogenomic deal structure
• Access to headline, upfront, milestone and royalty data
• Case studies of real-life pharmacogenomic deals
• Access to over 500 pharmacogenomic contract documents
• The leading pharmacogenomic deals by value since 2007
• Most active pharmacogenomic dealmakers since 2007
• The leading pharmacogenomic partnering resources

In Pharmacogenomic Partnering Terms and Agreements, the available contracts are listed by:

• Company A-Z
• Headline value
• Stage of development at signing
• Deal component type
• Specific therapy target

Each deal title links via Weblink to an online version of the deal record and where available, the contract document, providing easy access to each contract document on demand.

Pharmacogenomic Partnering Terms and Agreements provides the reader with the following key benefits:

• In-depth understanding of pharmacogenomic deal trends since 2007
• Access to headline, upfront, milestone and royalty data
• Analysis of the structure of pharmacogenomic agreements with numerous real life case studies
• Comprehensive access to over 500 actual pharmacogenomic contracts entered into by the world’s biopharma companies
• Detailed access to actual pharmacogenomic contracts enter into by the leading fifty bigpharma companies
• Insight into the terms included in a pharmacogenomic agreement, together with real world clause examples
• Understand the key deal terms companies have agreed in previous deals
• Undertake due diligence to assess suitability of your proposed deal terms for partner companies

Patient Monitoring Devices Market to 2017 - Increasing Use of Wireless Remote Patient Monitoring to be the Key Technology Trend

GBI Research’s report, “Global Patient Monitoring Devices Market to 2017 - Increasing Use of Wireless Remote Patient Monitoring to be the Key Technology Trend” shows how rising prevalence of chronic diseases, the growing elderly population and advances in wireless and sensors technologies are driving the market globally. The report provides key data, information and analysis on the global patient monitoring devices market, covering the market landscape, competitive landscape and market trends relating to seven patient monitoring devices market categories: remote patient monitoring devices, micro-electro mechanical systems, patient monitoring accessories, non-invasive blood pressure monitors, multiparameter patient monitoring devices, neonatal monitors and fetal monitors.

Reasons to Buy

• Develop business strategies by understanding the trends and developments that are driving the patient monitoring devices market.
• Design and develop your product development, marketing and sales strategies.
• Capitalize on M&A opportunities by identifying key companies with the most innovative pipeline.
• Develop market entry and market expansion strategies.
• Identify the key companies that are best positioned to take advantage of emerging market opportunities.
• Exploit in-licensing and out-licensing opportunities by identifying the products most likely to ensure a robust return.
• Identify, understand and capitalize on the next big thing in the patient monitoring devices market landscape
• Make more informed business decisions from the insightful and in-depth analysis of the patient monitoring devices market and the factors shaping it.

Wireless Remote Patient Monitoring Device Market

Published: March 2012
Price: Single User License: US$ 3500          Corporate User License: US$ 10500





The report Provides comprehensive information on the key trends affecting these categories, and key analytical content on the market dynamics, the report also reviews the competitive landscape and gives a detailed analysis of the pipeline products in each category. Details of important merger and acquisition deals that have taken place in the patient monitoring devices market are also reviewed. This report is built using data and information sourced from proprietary databases, primary and secondary research and in-house analysis by GBI Research’s team of industry experts.

Scope

• Key geographies: the US, Canada, the UK, Germany, France, Italy, Spain, Japan, China, India, Australia, and Brazil.
• Market size for seven patient monitoring devices market categories: remote patient monitoring devices, micro-electro mechanical systems, patient monitoring accessories, non-invasive blood pressure monitors, multiparameter patient monitoring devices, neonatal monitors and fetal monitors.
• Annualized market revenues data for 2003–2010, and forecasts for 2010–2017.
• Qualitative analysis of key market trends, market drivers, and restraints by each category within the patient monitoring devices market.
• The report also covers information on the leading companies currently operating in the market, the competitive landscape, and the leading technologies.
• Key players include Philips Healthcare, GE Healthcare, Omron Healthcare Co.,

Remote Patient Monitoring Devices Market to 2017 - Chronic Disease Prevalence and Government Curbs on Hospital Spending to Drive the Market

The report "Remote Patient Monitoring Devices Market to 2017 - Chronic Disease Prevalence and Government Curbs on Hospital Spending to Drive the Market” provides key data, information and analysis on the global remote patient monitoring (RPM) market. The report provides information on the market landscape, competitive landscape and market trends for two RPM market categories: external RPM devices and implantable RPM devices. The report also provides comprehensive information on the key trends affecting these categories and analytical content on market dynamics. The report also reviews the competitive landscape, covering the major acquisitions and mergers in the last three years and providing detailed analysis of the pipeline products in each category. This report is built using data and information sourced from proprietary databases, primary and secondary research and in-house analysis by GBI Research’s team of industry experts.

Remote Patient Monitoring Devices Market

Published: March 2012
Price: Single User License: US$ 3500          Corporate User License: US$ 10500

Reasons to Buy
The report will enhance your decision making capability. It will allow you to:

• Develop business strategies by understanding the trends and developments that are driving the RPM market globally.
• Design and develop your product development, marketing and sales strategies.
• Exploit M&A opportunities by identifying market companies with the most innovative pipeline.
• Develop market entry and market expansion strategies.
• Identify the key companies that are best positioned to take advantage of emerging market opportunities.
• Exploit in-licensing and out-licensing opportunities by identifying products that are most likely to ensure a strong return.
• What’s the next big thing in the RPM market landscape? – Identify, understand and capitalize.
• Make more informed business decisions from the insightful and in-depth analysis of the global RPM market and the factors that shape it.

Scope

• The report analyzes the RPM market, the key forces driving the current market and the potential challenges that could restrain growth. The scope of the report includes:
• Key countries covered: the US, Canada, the UK, Germany, France, Italy, Spain, Japan, China, India, Australia and Brazil.
• Market size data for two RPM market categories: external RPM devices and implantable RPM devices.
• Annualized market revenue data, forecast seven years to 2017, and company shares data for 2010.
• Qualitative analysis of key market trends in the global RPM market.

Explore all Patient Monitoring Research Reports

Medical Imaging Information Systems Market to 2017 - Replacement of Legacy Systems and Advances in Software Present Growth Opportunities

GBI Research’s report, “Medical Imaging Information Systems Market to 2017 - Replacement of Legacy Systems and Advances in Software Present Growth Opportunities” provides key data, information and analysis on the global Medical Imaging Information Systems (MIIS) market. The report provides information on the market landscape and market dynamics for the three market categories: Picture Archiving and Communication Systems (PACS), Radiology Information Systems (RIS) and Cardiology Information Systems. The report provides comprehensive information on the key factors affecting these categories, as well as key analytical content on the market dynamics and strategic competitive analysis.

Reasons to Buy
The report will enhance your decision making capability. It will allow you to:

• Develop business strategies by understanding the trends and developments that are driving the global MIIS market.
• Design and develop your product development, marketing and sales strategies. .
• Develop market-entry and market expansion strategies.
• Identify key players best positioned to take advantage of the market opportunities.
• What’s the next big thing in the MIIS market landscape? – Identify, understand and capitalize.
• Make more informed business decisions from the insightful and in-depth analysis of the MIIS market and the factors shaping it.

Medical Imaging Information Systems Market

Published: March 2012
Price: Single User License: US$ 3500        Corporate User License: US$ 10500





Scope

• The report analyses the global MIIS market along with the major forces driving the current market and the potential challenges that can restrict growth. The scope of the report includes:
• Key geographies covered include the US, Canada, the UK, France, Germany, Italy, Spain, Japan, China, Australia, India, and Brazil.
• Market size data for three MIIS market categories: PACS, RIS and Cardiology Information System.
• Annualized market revenue data, forecast for seven years to 2017. Company shares data for 2010.
• Qualitative analysis of key market trends for MIIS.
• Qualitative analysis of market drivers and restraints by each category within the MIIS market.
• Information on the leading market players and the competitive landscape.

Major points covered in Table of Contents of this report include

1 Table Of Contents 2
2 Executive Summary 11
3 Introduction 15
4 Medical Imaging Information Systems: Overview 16
5 Medical Imaging Information Systems: Market Characterization 18
6 Medical Imaging Information Systems Market: Segment Analysis and Forecasts 33
7 Medical Imaging Information Systems Market, Revenue ($m), by Country, Historic and Forecast, 2003–2017 50
8 Medical Imaging Information Systems, Market Opportunities and Risk Evaluation 78
9 Medical Imaging Information Systems, Key Market Participants and Internal Factor Analysis 80
10 Medical Imaging Information Systems Market: M&A Landscape 92
11 Appendix 95
List of Tables
List of Figures

View all Medical Imaging Market Reports

Electronic Medical Records Market to 2017 - Government Financial Incentives and Benefits in terms of Costs and Quality of Healthcare Drive Adoption among Physicians and Hospitals

This research provides key data, information and analysis on the global Electronic Medical Records (EMR) market. The report provides information on the market landscape and market dynamics for the two market categories: Hospital/ Enterprise EMR and Ambulatory EMR. The report provides comprehensive information on the key factors affecting these categories, as well as key analytical content on the market dynamics and strategic competitive analysis. This report is built using data and information sourced from proprietary databases, primary and secondary research and in-house analysis by GBI Research’s team of industry experts.

Scope

• The report analyses the global EMR market along with the major forces driving the current market and the potential challenges that can restrict growth. The scope of the report includes:
• Key geographies covered include the US, Canada, the UK, France, Germany, Italy, Spain, Japan, China, Australia, India, and Brazil.
• Market size data for two EMR market categories: Hospital/ Enterprise EMR and Ambulatory EMR.
• Annualized market revenue data, forecast for seven years to 2017. Company shares data for 2010.
• Qualitative analysis of key market trends, drivers and restraints for the EMR market.
• Information on the leading market players and the competitive landscape.

Electronic Medical Records Market

Published: March 2012
Price: Single User License: US$ 3500          Corporate User License: US$ 10500



Reasons to Buy

• The report will enhance your decision making capability. It will allow you to:
• Develop business strategies by understanding the trends and developments that are driving the global EMR market.
• Design and develop your product development, marketing and sales strategies. .
• Develop market-entry and market-expansion strategies.
• Identify key players best positioned to take advantage of the market opportunities.
• What’s the next big thing in the EMR market landscape? – Identify, understand and capitalize.
• Make more informed business decisions from the insightful and in-depth analysis of the EMR market and the factors shaping it.

Major points covered in Table of Contents of this report include

1 Table Of Contents 2
2 Executive Summary 12
3 Introduction 16
4 Electronic Medical Records: Overview 17
5 Electronic Medical Records: Global Market Characterization 20
6 Electronic Medical Records Market: Segment Analysis and Forecasts 42
7 Electronic Medical Records Market, Revenue ($m), by Geography, Revenue ($m), Historic and Forecast, 2003–2017 48
8 Electronic Medical Records Market: Key Global Market Participants and Marketed Products Analysis 819 Electronic Medical Records Market: Global M&A Landscape 96
10 Appendix 102
List of Tables

European Photochromic Lenses Market to 2017 - Enhanced Vision Quality and End-User Convenience Increases Demand

GBI Research’s report, “European Photochromic Lenses Market to 2017 - Enhanced Vision Quality and End-User Convenience Increases Demand” provides key data, information and analysis on the photochromic lenses market in Europe. The report provides a market landscape, key company profiles and market trend information on the photochromic lenses market in Europe. It provides comprehensive information on the key trends affecting photochromic lenses and key analytical content on the market dynamics. It reviews details regarding important deals that have taken place in the photochromic lenses market. This report is built using data and information sourced from proprietary databases, primary and secondary research and in-house analysis by GBI Research’s team of industry experts.

Related Industry Reports

• Ophthalmic Devices Market to 2017 - Glaucoma and Cataract Surgery Devices, Minimally Invasive Procedures in Ophthalmic Surgery to Drive the Ophthalmic Surgery Market
• The Future of Ophthalmic Devices, Market Forecasts and Growth Opportunities to 2016 - The Vision Care Segment Emerges as a Key Revenue Generator

European Photochromic Lenses Market

Published: March 2012
Price: Single User License: US$ 3500                 Corporate User License: US$ 10500

Scope

• Key geographies covered include the UK, Germany, France, Italy and Spain.
• The market size is given for the European glass and non-glass photochromic lenses market.
• Annualized market revenues data for 2003–2010 and forecasts for 2010–2017.
• Qualitative analysis of key market trends, market drivers, and restraints affecting the photochromic lenses market.
• The report also covers information on the leading companies currently operating in the market, the competitive landscape and the leading technologies.

Reasons to Buy

• Develop business strategies by understanding the trends and developments that are driving the photochromic lenses market.
• Design and develop your product development, marketing and sales strategies.
• Capitalize on M&A opportunities by identifying key companies with the most innovative pipeline.
• Develop market entry and market expansion strategies.
• Identify the key companies best positioned to take advantage of emerging market opportunities.
• Exploit in-licensing and out-licensing opportunities by identifying the products most likely to ensure a robust return.
• Identify, understand and capitalize on the next big thing in the photochromic lenses market landscape.
• Make informed business decisions from the insightful and in-depth analysis of the photochromic lenses market and the factors shaping it.

View all Surgical Equipment Research Reports

MEMJET COMPANY PROFILE

360° analysis of MEMJET technology, supply chain, strategy and market potential
In 2007 MEMJET Inc. has been created as a Spin-off from Silverbrook Research, a private Institute based in Balmain, Australia. With more than 3,000 patents related to Inkjet printing technologies, Silverbrook paves the way for a unique wide-page printhead module for single pass printing: “MEMJET Technology” was born. Between 2007 up to today, periods of press releases are followed by quiet periods, increasing interest and curiosity of the printing industry. Finally, MEMJET unveiled the first OEM product with “MEMJET Technology” inside.

The report provides details on:

• MEMJET technology and printhead costs
• Supply chain operation and suppliers
• Company strategy
• Estimated market potential and sales forecast 2011 – 2016

MEMJET IDENTITY

MEMJET company history and current organization worldwide:

• History of MEMJET and links with Silverbrook Reseach, the private institute developing MEMJET Technology are described in the report to show synergies between those private companies.
• MEMJET Inc. worldwide organization around its 4 main business units: Home and Office Printing, Label Printing, Wide Format printing, Photo retail.
• Key people from MEMJET
• MEMJET Business model: an original model in the inkjet industry with strong partners to supply MEMJET Technology.
• MEMJET is not only revolutionizing with its new technology, but also from its organization the choice of business model.

MEMJET Company Profile Market

Published: March 2012
Price: Single User License: US$ 5390

PRODUCTS AND MARKETS
MEMJET is currently addressing 3 market applications – Home & Office, Label Printing, Wide format - and one to be unveiled soon – Photo retail. Through its OEM partners, MEMJET is claiming one of the speediest inkjet printing system of the industry, and the easiest devices for printhead changes and maintenance.

Office market is key for MEMJET, positioning the technology as a strong competitor for Laser systems, gathering the best of Inkjet and laser.

MEMJET printhead module is scheduled to grow at a 64% CAGR from 2012, becoming a key inkjet printhead and module supplier.

MEMJET PRINTHEAD TECHNOLOGY
Based on 11 assembled MEMS printhead dies, MEMJET printhead module is a wide-page device, made of 5 ink channels. The innovative triangle shape at the interface allows a continuous 1,600dpi resolution. The 70,400 nozzles eject inks using a suspended heater produced by the use of MEMS processes.

Manufacturing of the ink holes by MEMS processes, ink ejection chambers and nozzles, as well as final module assembly is described in the report with a full process flow

WHO SHOULD BUY THIS REPORT ?
Inkjet printer companies developing their own system and in need to benchmark competitors.
OEM hardware printing companies which evaluate their interest to collaborate.
Possible service suppliers in the industrial chain with an interest in MEMJET as a possible customer.

OBJECTIVES OF THE REPORT
Provide information on the MEMJET company, a new player in the Inkjet printing industry.
MEMJET identity
Business model
Relationship with key partners

Pricing and Reimbursement of the Healthcare System in India- Low Levels of Drug Reimbursement Lead to a High Out-Of-Pocket Expenditure

The report “Pricing and Reimbursement in India- Low Levels of Drug Reimbursement Lead to a High Out-Of-Pocket Expenditure” closely scrutinizes the major changes in pharmaceuticals related pricing and reimbursement in the recent past, and the impact these changes will have in the future. The health insurance is responsible for facilitating demand by making high-cost prescription drugs more affordable. Although the per capita income is rising in India, the modest income of most of the population keeps the high cost drugs and medicines out of reach of the majority of the population. Drugs would become more expensive with the enforcement of product patents and so the sales of the expensive drugs depend on the growth and the maturity of the health insurance sector. If the health insurance industry does not mature, the market for patented drugs would experience adverse effects. The next three to five years will see a significant growth and change in the Indian health insurance industry as new insurance players and insurance products respond to the increased demand. India has a dual system of care: a private fee-for-service based sector where the money is paid Out-Of-Pocket (OOP) by individual households and a tax-based public sector where the providers are salaried. The utilization of insurance under both these systems is partly restricted by the affordability of the individual household and availability of the budget. On the other hand, insurance, as a means of financing, is a far more sophisticated mechanism, requiring a comprehensive understanding of the failures that characterize health insurance markets.

Scope

• Detailed study of the healthcare systems and roles of the key insurance players in the drug reimbursement process
• Analysis of the major pricing and reimbursement mechanisms in India.
• Key trends that follow from the recent changes brought about in the pricing and reimbursement mechanism.
• Build an understanding of the possible major challenges brought about by the enactment of changes in the pricing and reimbursement scene in India.

India Healthcare System- Drug Pricing & Reimbursement Market

Published: March 2012

Price: Single User License: US$ 3500       Corporate User License: US$ 10500 

Reasons to Buy

• Build understanding of the pharmaceuticals related key pricing and reimbursement mechanisms in India and also specifically in some states of India.
• Optimize your investment through the identification and understanding of the changes in the pharmaceuticals regulatory mechanism in the Indian economy.
• Develop effective business strategies related to new drug launches through the analytical insight gained from key trends in the pricing and reimbursement scene of India.
• Improve negotiations with the government agencies to maximize reimbursement on the drugs by understanding the mechanism.

Related Industry Reports

• Regulatory Intelligence on Biologics Recalls – Immunoglobulins and Vaccines are Involved in More Recalls than Other Drug Classes
• Pricing and Reimbursement in the US – Non-LIS Beneficiaries Not Covered by Medicare Coverage Gap to Gain from Reduction in Out-of-Pocket Expenditure for Generic Drugs
• Endpoints-Clinical Trials in Orphan Diseases - Highest Number of Terminated Trials Focused on Mulitiple Myeloma
• Drug Recalls and Warning Letters - Increasing Numbers Caused by Manufacturing Errors and Regulatory Non-compliance Issues
• Monoclonal Antibodies Market to 2017 - Multiple Indication Approvals and the Potential for MAbs in Oncology and Autoimmune Diseases are Re-Shaping the Market

Anti-Hypertensives Market to 2017-Patent Expiries of Blockbusters such as Diovan, Micardis, Avapro and Atacand to Accelerate Erosion

The latest research Report “Anti-Hypertensives Market to 2017 – Patent Expiries of Blockbusters such as Diovan, Micardis, Avapro and Atacand to Accelerate Erosion”, which provides insights into the anti-hypertensives therapeutics market until 2017. This report is built using data and information sourced from proprietary databases, primary and secondary research and in-house analysis by GBI Research’s team of industry experts. The report provides an in-depth analysis of hypertension and pulmonary arterial hypertension. It also provides the share of generics in global anti-hypertensives and in each indication market. The report examines the global anti-hypertensives usage patterns. It includes the geographical distribution of hypertension and PAH disease markets across the US, the top five countries of Europe and in Japan. The report also includes insights into the anti-hypertensives Research and Development (R&D) product pipeline and explores the competitive landscape, including major players in the anti-hypertensives market. Finally, the report includes analysis on Mergers and Acquisitions (M&A) and licensing agreements that took place in the anti-hypertensives market.

Scope

• Data and analysis on the anti-hypertensives market in the leading geographies of the world – the US, the UK, Germany, France, Italy, Spain and Japan.
• Annualized market data for the anti-hypertensives market from 2002 to 2010, with forecasts to 2017.
• Market data on the geographical landscape and therapeutic landscape, including market size, market share, annual cost of therapy, sales volume and treatment usage patterns such as disease population, treatment seeking population, diagnosis population and prescription population.

Anti-Hypertensives Market

Published: March 2012
Price: Single User License: US$ 3500      Corporate User License: US$ 10500



The market is expected to witness a fluctuation due to patent expiries followed by generic erosion and the possible launch of novel molecules. The market is expected to witness comparatively slow growth with a CAGR of 1.2% between 2010 and 2017, to reach $32.6 billion in 2017. A steady increase in the hypertension and PAH prevalence population and the use of fixed dose combination drugs will drive the growth of the anti-hypertensives market in the future. The market for hypertension market is expected to slow down due to patent expiries of major blockbuster drugs. Recent and upcoming patent expiries of drugs are the only barrier to the global anti-hypertensives market. However, the expected launch of novel molecules with disease modifying characteristics and better safety and efficacy will drive the market in the forecast period.

Reasons to Buy

• Align your product portfolio to the markets with high growth potential.
• Build effective strategies to launch their pipeline products by identifying potential geographies.
• Exploit in-licensing and out-licensing opportunities by identifying products that might fill their portfolio gaps.
• Develop key strategic initiatives by studying the key strategies of top competitors.
• Create a more tailored country strategy through the understanding of key drivers and barriers and market potential of each indication.